Mangoceuticals (MGRX) Net Income towards Common Stockholders Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) Net Income towards Common Stockholders Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 14.35% |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 275.50% |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 28.75% |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | -71.96% |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | -69.40% |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 60.80% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 48.00% |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -38.64% |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 262.39% |
| 10 | Mangoceuticals | 6.01 Mn | 5.82 Mn | 29,001.00 | 27.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.98% |
| Dec 31, 2025 | -57.24% |
| Sep 30, 2025 | -245.02% |
| Jun 30, 2025 | -126.48% |
| Mar 31, 2025 | -116.82% |
| Dec 31, 2024 | 24.13% |
| Sep 30, 2024 | -27.44% |
| Jun 30, 2024 | -4.70% |
| Mar 31, 2024 | 7.55% |